[Federal Register Volume 87, Number 16 (Tuesday, January 25, 2022)]
[Notices]
[Page 3830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01345]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on March 8, 2022. The topic for this 
meeting will be ``Opportunities for Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.'' The meeting 
is open to the public.

DATES: The meeting will be held on March 8, 2022 from 8:30 a.m. to 4:45 
p.m. EDT.

ADDRESSES: The meeting will be held via an online video conferencing 
platform. Virtual attendance for the meeting will be accessible to 
members of the public who register at https://www.scgcorp.com/dmicc2022/Registration at least 5 days prior to the workshop.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, including a draft agenda, which will be posted when 
available, see the DMICC website, www.diabetescommittee.gov, or contact 
Dr. William Cefalu, Director, Division of Diabetes, Endocrinology, and 
Metabolic Diseases, National Institute of Diabetes and Digestive and 
Kidney Diseases, 6707 Democracy Boulevard, Democracy 2, Room 6037, 
Bethesda, MD 20892, telephone: 301-435-1011; email: [email protected].

SUPPLEMENTARY INFORMATION: In accordance with 42 U.S.C. 285c-3, the 
DMICC, chaired by the National Institute of Diabetes and Digestive and 
Kidney Diseases (NIDDK) and comprising members of the Department of 
Health and Human Services and other federal agencies that support 
diabetes-related activities, facilitates cooperation, communication, 
and collaboration on diabetes among government entities. DMICC 
meetings, held several times a year, provide an opportunity for 
Committee members to learn about and discuss current and future 
diabetes programs in DMICC member organizations and to identify 
opportunities for collaboration. The March 8, 2022 DMICC meeting will 
focus on ``Opportunities for Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.'' Any 
interested person may file written comments with the Committee by 
forwarding their statement to the contact person listed on this notice. 
The statement should include the name, address, telephone number and, 
when applicable, the business or professional affiliation of the 
interested person. Because of time constraints for the meeting, there 
will not be time on the agenda for oral comments from members of the 
public.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC website, www.diabetescommittee.gov.

    Dated: January 19, 2022.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2022-01345 Filed 1-24-22; 8:45 am]
BILLING CODE 4140-01-P